Pisa, Italy

Ugo Baldacci


Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 1995

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ugo Baldacci: Innovator in Pharmaceutical Oligosaccharides

Introduction

Ugo Baldacci is a notable inventor based in Pisa, Italy. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of complexable heterogeneous oligosaccharides and alpha-hydrosanes. His innovative work has the potential to enhance pharmacological effects through improved cellular permeability.

Latest Patents

Ugo Baldacci holds a patent for "Complexable heterogeneous oligosaccharides and alpha-hydrosanes." This invention involves the production of pure alpha-hydrosanes and complexable heterogeneous oligosaccharides derived from bovine or swine mucosa. The process includes precipitation with organic solvents, purification using specific enzymes, and chromatographic separation by gel filtration. The resulting oligosaccharides can complex with metals, promoting pharmacological effects due to increased permeability of cell membranes. The alpha-hydrosanes produced exhibit various pharmacological activities, including effects on anti-thrombine III and lipasemic activity.

Career Highlights

Ugo Baldacci is associated with Laboratori Baldacci S.p.a., where he continues to advance his research and development efforts. His work has been instrumental in exploring the therapeutic potential of oligosaccharides in medical applications.

Collaborations

Ugo collaborates with Massimo Baldacci, contributing to the innovative research environment at Laboratori Baldacci S.p.a. Their partnership enhances the development of new pharmaceutical solutions.

Conclusion

Ugo Baldacci's contributions to the field of pharmaceutical oligosaccharides demonstrate his commitment to innovation and research. His patented work has the potential to significantly impact pharmacological treatments and improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…